Joel Greenblatt Medpace Holdings, Inc. Transaction History

Gotham Asset Management, LLC

$16.1 Billion
Q2 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 14,376 shares of MEDP stock, worth $8.63 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,376

Previous 6,854 109.75%

Holding current value

$8.63 Million

Previous $2.09 Million 116.09%

% of portfolio

0.03%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$277.23 - $315.28 $2.09 Million - $2.37 Million	7,522 Added 109.75%	14,376 $4.51 Million
Q1 2025 May 15, 2025	BUY	$304.69 - $360.97 $335,463 - $397,427	1,101 Added 19.14%	6,854 $2.09 Million
Q4 2024 Feb 14, 2025	SELL	$308.93 - $363.58 $759,041 - $893,316	-2,457 Reduced 29.93%	5,753 $1.91 Million
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $745,989 - $1.06 Million	2,327 Added 39.55%	8,210 $2.74 Million
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $35,712 - $40,736	-96 Reduced 1.61%	5,883 $2.42 Million
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $287,148 - $416,616	-1,008 Reduced 14.43%	5,979 $2.42 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $32,535 - $44,713	-143 Reduced 2.01%	6,987 $2.14 Million
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $233,980 - $281,670	-1,000 Reduced 12.3%	7,130 $1.73 Million
Q2 2023 Aug 14, 2023	SELL	$187.26 - $240.17 $1.26 Million - $1.62 Million	-6,751 Reduced 45.37%	8,130 $1.95 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $1.18 Million - $1.62 Million	6,764 Added 83.33%	14,881 $2.8 Million
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $239,845 - $355,035	-1,567 Reduced 16.18%	8,117 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $53,843 - $67,703	371 Added 3.98%	9,684 $1.52 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $218,996 - $282,626	1,682 Added 22.04%	9,313 $1.39 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $36,383 - $56,149	-262 Reduced 3.32%	7,631 $1.25 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $182 - $227	-1 Reduced 0.01%	7,893 $1.72 Million
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $31,653 - $36,867	-186 Reduced 2.3%	7,894 $1.49 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $54,089 - $66,256	-341 Reduced 4.05%	8,080 $1.43 Million
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $69,442 - $88,504	-526 Reduced 5.88%	8,421 $1.38 Million
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $170,851 - $233,034	-1,562 Reduced 14.86%	8,947 $1.25 Million
Q3 2020 Nov 16, 2020	SELL	$92.95 - $130.61 $845,194 - $1.19 Million	-9,093 Reduced 46.39%	10,509 $1.17 Million
Q2 2020 Aug 13, 2020	SELL	$68.08 - $95.68 $2.38 Million - $3.34 Million	-34,898 Reduced 64.03%	19,602 $1.82 Million
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $1.94 Million - $3.2 Million	-31,435 Reduced 36.58%	54,500 $4 Million
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $1.64 Million - $1.98 Million	-23,424 Reduced 21.42%	85,935 $7.22 Million
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $1.34 Million - $1.85 Million	-21,533 Reduced 16.45%	109,359 $9.19 Million
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $303,495 - $370,146	-5,658 Reduced 4.14%	130,892 $8.56 Million
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $739,613 - $1.06 Million	-14,978 Reduced 9.88%	136,550 $8.05 Million
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $7.12 Million - $9.69 Million	151,528 New	151,528 $8.02 Million
Q1 2018 May 15, 2018	SELL	$32.03 - $39.05 $313,541 - $382,260	-9,789 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$32.46 - $38.31 $317,750 - $375,016	9,789	9,789 $355,000

Others Institutions Holding MEDP

# of Institutions

699

Shares Held

26.1M

Call Options Held

53.6K

Put Options Held

108K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $18.7B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account